Rallybio Corp (RLYB)
1.83
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
1.84
+0.01
(+0.55%)
After-Hours: 20:00
Rallybio 1 Year Total Returns (Daily): -66.11% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | -66.11% |
May 02, 2024 | -67.44% |
May 01, 2024 | -64.68% |
April 30, 2024 | -64.38% |
April 29, 2024 | -65.68% |
April 26, 2024 | -68.58% |
April 25, 2024 | -67.26% |
April 24, 2024 | -67.56% |
April 23, 2024 | -62.74% |
April 22, 2024 | -62.10% |
April 19, 2024 | -61.23% |
April 18, 2024 | -61.43% |
April 17, 2024 | -60.00% |
April 16, 2024 | -58.24% |
April 15, 2024 | -57.54% |
April 12, 2024 | -51.33% |
April 11, 2024 | -37.79% |
April 10, 2024 | -67.47% |
April 09, 2024 | -66.40% |
April 08, 2024 | -65.99% |
April 05, 2024 | -67.98% |
April 04, 2024 | -70.02% |
April 03, 2024 | -70.18% |
April 02, 2024 | -70.05% |
April 01, 2024 | -68.65% |
Date | Value |
---|---|
March 28, 2024 | -63.58% |
March 27, 2024 | -66.17% |
March 26, 2024 | -67.69% |
March 25, 2024 | -67.03% |
March 22, 2024 | -63.64% |
March 21, 2024 | -66.67% |
March 20, 2024 | -63.08% |
March 19, 2024 | -65.14% |
March 18, 2024 | -64.49% |
March 15, 2024 | -67.60% |
March 14, 2024 | -69.68% |
March 13, 2024 | -67.01% |
March 12, 2024 | -68.12% |
March 11, 2024 | -65.09% |
March 08, 2024 | -72.70% |
March 07, 2024 | -77.91% |
March 06, 2024 | -78.86% |
March 05, 2024 | -76.61% |
March 04, 2024 | -75.16% |
March 01, 2024 | -69.86% |
February 29, 2024 | -70.46% |
February 28, 2024 | -71.79% |
February 27, 2024 | -72.86% |
February 26, 2024 | -76.68% |
February 23, 2024 | -77.92% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-82.75%
Minimum
Jan 23 2024
34.35%
Maximum
Sep 20 2022
-46.57%
Average
-50.22%
Median
1 Year Total Returns (Daily) Benchmarks
Johnson & Johnson | -5.54% |
Adial Pharmaceuticals Inc | -77.50% |
Eliem Therapeutics Inc | 196.9% |
Alpine Immune Sciences Inc | 824.2% |
Monogram Orthopaedics Inc | -- |